Compared with melanoma, breast cancer, hepatocellular carcinoma, squamous cell carcinoma, and lung cancer cell lines, NPC cell lines SUNE-1 and 5-8F showed dramatically high levels of FGF-2 (Figure 2A), validating the results from clinical NPC samples and the database analysis. This evidence concerns the gene FGF2 and breast carcinoma.